Wait! Before you go..
Subscribe NOW and receive valuable new life sciences content weekly in the form of new blogs, presentations, podcast episodes, tips, resources and exclusive offers directly from Curtis & Coulter weekly to your inbox
Understanding the Importance of Excipient Selection for Controlled Release
Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products, and excipient selection is vitally important. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR)...
Overcoming Drug Development Barriers for Peptide Products: Analytical, Physical and Formulation Aspects
The popularity of peptide therapeutics has increased significantly in recent years. Compared with chemical drugs, peptide drugs have little side-effects and little drug tolerance. Meanwhile, the specificity of treatment is high. Peptides are recognized for being...
Commercial Advances in Drug Delivery Systems for Peptide-Based Therapeutics
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Why Should you Consider Developing Controlled and Modified-Release Drug Products?
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Recent Comments